Estrella Immunopharma annual current ratio
2021
2022
2022
2023
2024
2024
2025
Estrella Immunopharma Current Ratio Growth & History (ESLA)
Estrella Immunopharma's current ratio was 0.12 for fiscal 2025.
View full Estrella Immunopharma company overviewEstrella Immunopharma annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.12 | −0.42 | −77.38% |
| 2024 · Dec 31 | 2024-12-31 | 0.55 | — | — |
| 2024 · Jun 30 | 2024-06-30 | 24.65 | 24.37 | +8639.71% |
| 2023 | 2023-06-30 | 0.28 | −4.92 | −94.57% |
| 2022 | 2022-12-31 | 0.05 | −8.37 | −99.42% |
| 2022 | 2022-06-30 | 5.20 | — | — |
| 2021 | 2021-12-31 | 8.42 | — | — |
Estrella Immunopharma quarterly current ratio
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q4.23
Q2.24
Q3.24
Q4.24
Q1.25
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.20 | 0.03 | +20.84% |
| Q1 2026 | 2026-03-31 | 0.24 | 0.02 | +9.40% |
| Q4 2025 | 2025-12-31 | 0.12 | −0.42 | −77.38% |
| Q3 2025 | 2025-09-30 | 0.15 | −0.60 | −79.75% |
| Q2 2025 | 2025-06-30 | 0.16 | −24.49 | −99.34% |
| Q1 2025 · Mar 31 | 2025-03-31 | 0.22 | −62.12 | −99.65% |
| Q4 2024 · Dec 31 | 2024-12-31 | 0.55 | −23.15 | −97.69% |
| Q1 2025 · Sep 30 | 2024-09-30 | 0.75 | — | — |
| Q4 2024 · Jun 30 | 2024-06-30 | 24.65 | 24.37 | +8639.71% |
| Q3 2024 | 2024-03-31 | 62.34 | — | — |
| Q2 2024 | 2023-12-31 | 23.69 | 23.64 | +48394.94% |
| Q4 2023 | 2023-06-30 | 0.28 | −0.55 | −66.14% |
| Q4 2022 | 2022-12-31 | 0.05 | −8.37 | −99.42% |
| Q3 2022 | 2022-09-30 | 0.22 | −7.54 | −97.18% |
| Q2 2022 | 2022-06-30 | 0.83 | — | — |
| Q1 2022 | 2022-03-31 | 14.18 | — | — |
| Q4 2021 | 2021-12-31 | 8.42 | — | — |
| Q3 2021 | 2021-09-30 | 7.75 | — | — |
Estrella Immunopharma current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Estrella Immunopharma's current ratio decreased from 8.42 to 0.12, a change of −8.30. The latest reported quarter, Q2 2026, shows 0.20.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Estrella Immunopharma source filings ↗